Abstract: A full-area touch device includes a touch control assembly, a plurality of support elastic sheet assemblies, a support frame and a limiting unit structure. The touch control assembly is movably disposed on the support frame. The support elastic sheet assemblies is disposed between the touch control assembly and the support frame to enable the touch control assembly to move relative to the support frame between an unpressed position and a pressed position. The limiting unit structures is disposed between the touch control assembly and the support frame for limiting height position and travel distance of the touch control assembly.

Abstract: A full-area touch device includes a touch control assembly, a plurality of support elastic sheet assemblies, a support frame and a limiting unit structure. The touch control assembly is movably disposed on the support frame. The support elastic sheet assemblies is disposed between the touch control assembly and the support frame to enable the touch control assembly to move relative to the support frame between an unpressed position and a pressed position. The limiting unit structures is disposed between the touch control assembly and the support frame for limiting height position and travel distance of the touch control assembly.

Abstract: A gene knockin method and a kit for gene knockin are provided.

Abstract: Methods are disclosed herein for increasing bone mass and strength or bone fracture healing in a subject. The methods include administering to the subject a therapeutically effective amount of multipotent stem cells, wherein each multipotent stem cell is transformed with a recombinant nucleic acid molecule comprising a heterologous promoter operably linked to a nucleic acid encoding platelet derived growth factor (PDGF) B, and wherein the multipotent stem cells express a sufficient amount of PDGFB to increase bone mass and strength or bone fracture healing. A lentiviral vector also is disclosed that includes a phosphoglycerate kinase-1 (PGK) promoter operably linked to a nucleic acid encoding PDGFB.

Abstract: Methods are disclosed herein for increasing bone mass and strength or bone fracture healing in a subject. The methods include administering to the subject a therapeutically effective amount of multipotent stem cells, wherein each multipotent stem cell is transformed with a recombinant nucleic acid molecule comprising a heterologous promoter operably linked to a nucleic acid encoding platelet derived growth factor (PDGF) B, and wherein the multipotent stem cells express a sufficient amount of PDGFB to increase bone mass and strength or bone fracture healing. A lentiviral vector also is disclosed that includes a phosphoglycerate kinase-1 (PGK) promoter operably linked to a nucleic acid encoding PDGFB.

Abstract: A housing for an electronic device and a method for making the same are disclosed, the housing comprises a transparent base layer including an inner surface and an outer surface, an opaque screen ink layer printed on the inner surface of the base layer and surrounding a display screen, a transparent outer ink layer printed on substantially the entire outer surface of the base layer to protect the base layer.